WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009131696) TREATMENT OF HEPATITIS C VIRUS INFECTIONS WITH TELAPREVIR (VX-950) IN PATIENTS NON-RESPONSIVE TO TREATMENT WITH PEGYLATED INTERFER0N-ALPHA-2A/2B AND RIBAVIRIN
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/131696    International Application No.:    PCT/US2009/002526
Publication Date: 29.10.2009 International Filing Date: 23.04.2009
IPC:
A61K 31/454 (2006.01), A61K 38/21 (2006.01), A61P 1/16 (2006.01), A61P 31/14 (2006.01), A61P 31/12 (2006.01), A61K 31/13 (2006.01), A61K 31/7056 (2006.01), A61K 31/7072 (2006.01)
Applicants: VERTEX PHARMACEUTICALS INCORPORATED [US/US]; 130 Waverly Street Cambridge, MA 02139-4242 (US) (For All Designated States Except US).
MCNAIR, Lindsay [US/US]; (US) (For US Only).
JACOBSON, Ira [US/US]; (US) (For US Only).
MCHUTCHISON, John [US/US]; (US) (For US Only)
Inventors: MCNAIR, Lindsay; (US).
JACOBSON, Ira; (US).
MCHUTCHISON, John; (US)
Agent: O'BRIEN, Jonathan, P.; (US)
Priority Data:
61/161,681 19.03.2009 US
61/109,805 30.10.2008 US
61/060,008 30.07.2008 US
61/099,452 23.09.2008 US
61/047,336 23.04.2008 US
61/152,535 13.02.2009 US
Title (EN) TREATMENT OF HEPATITIS C VIRUS INFECTIONS WITH TELAPREVIR (VX-950) IN PATIENTS NON-RESPONSIVE TO TREATMENT WITH PEGYLATED INTERFER0N-ALPHA-2A/2B AND RIBAVIRIN
(FR) TRAITEMENT D'INFECTIONS PAR LE VIRUS DE L'HÉPATITE C CHEZ DES PATIENTS NON SENSIBLES À UN TRAITEMENT PAR L'INTERFÉRON-ALPHA-2A/2B PEGYLÉ ET LA RIBAVIRINE
Abstract: front page image
(EN)The present invention relates to antiviral therapies and compositions for treating or preventing Hepatitis C infections in patients and relates to other methods disclosed herein. The invention also relates to kits and pharmaceutical packs comprising compositions and dosage forms. The invention also relates to processes for preparing these compositions, dosages, kits, and packs.
(FR)La présente invention porte sur des thérapies antivirales et sur des compositions pour traiter ou prévenir des infections par l'Hépatite C chez des patients ainsi que sur d'autres procédés décrits ici. L'invention porte également sur des coffrets et des conditionnements pharmaceutiques comportant des compositions et des formes pharmaceutiques. L'invention porte également sur des procédés pour préparer ces compositions, ces formes pharmaceutiques, ces coffrets et ces conditionnements.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)